News & Blog

GBM AGILE: A Community Galvanized

“GBM is just unacceptable…we no longer accept the status quo.” – Dr. Anna Barker Last week, you likely took notice of the press release, guest blog from Dr. Anna Barker, and a flurry of social media activity related to the announcement of the GBM AGILE coalition and clinical trial. As NBTS is co-chairing the GBM […]

Our Bold Response to the Deadliest of Brain Cancers

It’s long past time to act – the time is now! This year, tens of thousands of individuals around the globe will be diagnosed with glioblastoma (GBM) – the most common and deadliest of malignant adult brain tumors. It is cancerous and highly aggressive. This disease took the lives of Ted Kennedy, Beau Biden, and so many others over the course of this year and every year. Fifty percent of GBM […]

Telling the Truth, the Whole Truth, and Nothing But the Truth on EGFR

Summary: Defeat GBM-funded research discovers a completely new process whereby EGFR alterations – which occur in the majority of GBMs – fuel tumor growth, and, importantly, identifies a potential way to exploit these changes in tumor cells to treat GBM using a class of anti-cancer drugs already in development. The majority of cells within the human […]